P-53 Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial
Titel:
P-53 Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial
Auteur:
Pittock, S. Barnett, M. Bennett, J.L. Berthele, A. de Sèze, J. Levy, M. Nakashima, I. Oreja-Guevara, C. Palace, J. Paul, F. Pozzilli, C. Allen, K. Mashhoon, Y. Yountz, M. Kim, H.J.